Recursion Pharmaceuticals
Price & Volume
Stats
See more52W Range | $3.79-$12.36 |
Market Cap | $2.4B |
Shares Short | 126M |
Financials
See moreRevenue (12 Mos) | $43.6M |
Revenue Growth (YoY) | -80.2% |
Gross Profit (12 Mos) | -$362.4M |
Diluted EPS | -$1.84 |
News
See moreYahoo Finance • 3 days ago
Will Recursion Pharmaceuticals’ (RXRX) New CEO Accelerate Its AI Ambitions and Strategic Partnerships?
Yahoo Finance • 5 days ago
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
Yahoo Finance • 5 days ago
Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
Yahoo Finance • 17 days ago
AI in Biotechnology Market to Reach $11.4 Billion by 2030
About
CEO | Dr. Christopher C. Gibson Ph.D. |
CFO | Mr. Ben R. Taylor |
Address | 41 South Rio Grande Street, Salt Lake City, UT, United States, 84101 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 800 |
